Very Gently
How PlexusDx Supports a More Personalized Approach PlexusDx's Precision Peptide Genetic Test examines variants in GLP-1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313)genes that regulate appetite signaling and GLP-1 pathway sensitivity
While GLP-1 medications were initially developed for type 2 diabetes, they are also approved for weight management in individuals without diabetes who have obesity or are overweight with a related health condition
Give them a call or send email or whatever so you're not left hanging for a while
The study included five cohorts, each receiving 12 once-weekly (QW) SC doses of MET-097i across various dose levels (0.4 mg to 1.2 mg), followed by a single higher-dose administration intended to simulate monthly dosing (2 or 4 the weekly dose)
If youre navigating ADHD, metabolic challenges, or both, an integrated, evidence-based approach matters